Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BW-20805 by Shanghai Argo Pharmaceutical for Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency): Likelihood of Approval
BW-20805 is under clinical development by Shanghai Argo Pharmaceutical and currently in Phase I for Hereditary Angioedema (HAE) (C1 Esterase...